Skip to main content
. 2021 Jun 4;13(11):2804. doi: 10.3390/cancers13112804

Table 2.

Transcription factors for ITGA6 or ITGB1.

Gene Symbol Gene Name Expression in ICC 1 Cancer
Tissues (p-Value)
Correlation with ITGA6 (p-Value) Correlation with ITGB1 (p-Value) miR-29-3p Binding Site Reference
SP1 Sp1 transcription factor <0.01 <0.01 <0.01 + [24,25]
CREB1 cAMP responsive element binding protein 1 <0.01 <0.01 <0.01 [25]
MAX MYC associated factor X <0.01 <0.01 0.011 [25]
FHL2 four and a half LIM domains 2 <0.01 <0.01 <0.01 [25]
RFX1 regulatory factor X, 1 (influences HLA class II expression) <0.01 <0.01 <0.01 [25]
HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) <0.01 <0.01 0.019 [25]
TFAP2A transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) <0.01 N.S <0.01 [25]
CUX1 cut-like homeobox 1 <0.01 <0.01 N.S [25]
USF1 upstream transcription factor 1 <0.01 N.S <0.01 [25]
TFAP2C transcription factor AP-2 gamma (activating
enhancer binding protein 2 gamma)
<0.01 N.S N.S + [25]
FOXM1 forkhead box M1 <0.01 N.S N.S [26]
SPI1 Spi-1 proto-oncogene <0.05 N.S N.S [25]
MXI1 MAX interactor 1, dimerization protein N.S 2 0.011 N.S + [25]
PAX6 paired box 6 N.S <0.01 <0.01 [25]
ESR1 estrogen receptor 1 N.S 0.015 <0.01 [25]
MEF2A myocyte enhancer factor 2A N.S <0.01 0.038 [25]
HOXD3 homeobox D3 N.S 0.012 N.S [25]
MYC MYC proto-oncogene,
bHLH transcription factor
N.S N.S N.S [25]

1 Intrahepatic cholangiocarcinoma, 2 No significant difference.